PEAK6 Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.07M Sell
71,600
-242,800
-77% -$7.08M ﹤0.01% 1492
2024
Q2
$8.8M Buy
314,400
+251,500
+400% +$6.92M 0.02% 541
2024
Q1
$1.75M Sell
62,900
-49,100
-44% -$1.36M ﹤0.01% 1545
2023
Q4
$3.22M Buy
112,000
+9,100
+9% +$275K 0.01% 1146
2023
Q3
$3.41M Buy
102,900
+20,200
+24% +$714K 0.02% 967
2023
Q2
$3.03M Buy
82,700
+63,000
+320% +$2.45M 0.01% 928
2023
Q1
$804K Sell
19,700
-177,200
-90% -$7.65M ﹤0.01% 2013
2022
Q4
$10.1M Buy
196,900
+78,900
+67% +$3.78M 0.06% 374
2022
Q3
$5.16M Sell
118,000
-354,200
-75% -$17.2M 0.02% 813
2022
Q2
$23.5M Buy
472,200
+59,600
+14% +$3.04M 0.04% 413
2022
Q1
$21.4M Sell
412,600
-673,600
-62% -$35M 0.05% 380
2021
Q4
$64.1M Buy
1,086,200
+65,500
+6% +$3.25M 0.14% 136
2021
Q3
$43.9M Buy
1,020,700
+498,643
+96% +$22.1M 0.1% 175
2021
Q2
$28.4M Buy
522,057
+403,857
+342% +$15.7M 0.07% 262
2021
Q1
$4.28M Sell
118,200
-116,825
-50% -$4.15M 0.01% 1179
2020
Q4
$8.65M Sell
235,025
-394,424
-63% -$14.5M 0.02% 746
2020
Q3
$21.9M Buy
629,449
+283,421
+82% +$9.94M 0.05% 304
2020
Q2
$10.7M Buy
346,028
+94,333
+37% +$3.2M 0.04% 461
2020
Q1
$7.79M Buy
251,695
+246,530
+4,773% +$8.4M 0.05% 373
2019
Q4
$192K Sell
5,165
-28,985
-85% -$1.03M ﹤0.01% 2567
2019
Q3
$1.16M Buy
+34,150
New +$1.24M 0.01% 1649
2019
Q2
Sell
-26,350
Closed -$1.06M 4149
2019
Q1
$1.06M Sell
26,350
-257,387
-91% -$10.3M 0.01% 1796
2018
Q4
$11.8M Sell
283,737
-617,644
-69% -$25.6M 0.07% 289
2018
Q3
$37.7M Buy
+901,381
New +$34.7M 0.16% 101

Other funds holding PFE

PEAK6 Investments's PFE Position: Q3 2024 in Review

PEAK6 Investments sold out of Pfizer (PFE) in Q3 2024, closing a stake of 27,903 shares — an estimated $814K sold.

PEAK6 Investments first reported a position in PFE in Q1 2019 and held it in 19 quarters. The position peaked at $9.74M in Q1 2020. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • PEAK6 Investments reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 27,903 Pfizer shares in Q3 2024, an estimated $814K.
  • PEAK6 Investments first reported a position in Pfizer in Q1 2019 and held it in 19 quarters.
  • PEAK6 Investments's Pfizer position peaked at $9.74M in Q1 2020.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.